Purchases and Sales Made in Q2 2025 in Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT) during Q2 2025. The information is specifically focused on institutions that hold shares of EyePoint Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2025
Q2 2025
|
Blue Owl Capital Holdings LP
New York, NY |
SELL
|
- |
-235K- 29.46% |
$971K - $2.48M
|
563K
$6.05M
|
|
|
Aug 14, 2025
Q2 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-251K- 16.38% |
$1.04M - $2.64M
|
1.28M
$13.8M
|
|
|
Aug 14, 2025
Q2 2025
|
Ubs Group Ag
|
SELL
|
- |
-261K- 67.41% |
$1.08M - $2.75M
|
126K
$1.36M
|
|
|
Aug 14, 2025
Q2 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.27M- 93.82% |
$5.25M - $13.4M
|
83.7K
$900K
|